1. Oxford Health Libraries NHS
  2. Conditions, Lifestyle Factors & Interventions
  3. Conditions
  4. Schizophrenia and Psychotic Disorders
Please use this identifier to cite or link to this item: https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/122
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLennox, Belinda
dc.contributor.authorTomei, Giuliano
dc.contributor.authorVincent, Sally-Anne
dc.contributor.authorYeeles, Ksenija
dc.contributor.authorPollard, Rebecca
dc.date.accessioned2018-10-25T22:13:21Z
dc.date.available2018-10-25T22:13:21Z
dc.date.issued2018-06-11
dc.identifier.citationBelinda R Lennox, Giuliano Tomei,Sally-Anne Vincent, Ksenija Yeeles,Rebecca Pollard, Emma Palmer-Cooper,Peter Jones, Michael S Zandi, Alasdair Coles. Study of immunotherapy in antibody positive psychosis: feasibility and acceptability (SINAPPS1) J Neurol Neurosurg Psychiatry June 2018en
dc.identifier.issn1468-330X
dc.identifier.urihttps://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/122
dc.descriptionCopyright information: © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. Eligible users can access the full text via NHS OpenAthens (login required).en
dc.description.abstractThe main finding of the SINAPPS1 study is that immunotherapy can be delivered rapidly and safely to people with acute psychosis within an acute hospital setting. The treatments were tolerated and there were no cases of worsening of psychotic symptoms, even with the use of corticosteroids. At 1 month after presentation, all patients had improved, although an uncontrolled study of this size cannot determine causality; that is the aim of the on-going randomised placebo-controlled SINAPPS2 trial, whose design was influenced by the current trial.en
dc.description.sponsorshipThe study was funded by The Stanley Medical Research Institute (14T-004).en
dc.description.urihttp://dx.doi.org/10.1136/jnnp-2018-318124
dc.language.isoenen
dc.subjectImmunotherapyen
dc.subjectPsychosisen
dc.subjectEncephalitisen
dc.titleStudy of immunotherapy in antibody positive psychosis: feasibility and acceptability (SINAPPS1)en
dc.typeArticleen
Appears in Collections:Schizophrenia and Psychotic Disorders

Files in This Item:
File Description SizeFormat 
SINAPPS1 Final Report Summary1.docPre-Print45.5 kBMicrosoft WordView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.